US-based Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, ...
NGeneBio, a precision diagnosis platform based on next-generation sequencing (NGS), has signed a business agreement ...
South Korea-based firms Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agre...
A research team from Korea Advanced Institute of Science and Technology (KAIST) has developed a highly sensitive, wearab...
South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...
West Pharmaceutical Services, Inc. has announced the extension of its complete containment solution, Ready Pack, in...
Neurophet, a company specialising in artificial intelligence (AI) solutions for brain disease imaging, has obtained medi...
South Korea based Standigm, a company using artificial intelligence (AI) technology for drug discovery and developm...
A team of researchers at South Korea-based Pohang University of Science and Technology (POSTECH) and at Eunpyeong St. Ma...
South Korea-based GC Genome Corporation has announced the publication of a new study in Nature Communications, show...
Title: Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk Date: May 24, 2023 Synopsis ...
Taiwan-based Bora Pharmaceuticals Co. and Celltrion Asia Pacific, a subsidiary of South Korea-based Celltrion Group Inc,...
Standigm, a South Korea-based startup using artificial intelligence (AI) technology for drug discovery and development, ...
Hugel, a South Korea-based medical aesthetics company, has announced the appointment of Suk-yong Cha, former Vice c...
South Korea-based firm Seegene and the International Vaccine Institute (IVI), an international organisation dedicated to...
A research team from South Korea-based Pohang University of Science and Technology (POSTECH) collaborated with researche...
Proteomics has developed a versatile platform technology for discovering diagnostic tests based on differences in protei...
DXVX has announced that its affiliated company Oxford Vacmedix (OVM) has completed Phase 1a trial of cancer vaccine and ...
